Features

Our editorial board comprises a specialist group of leading industry figures who, in conjunction with the drug development technology editorial team, identify the main drivers of the industry helping to produce regular, thought provoking opinion pieces on the latest issues, challenges and developments.

Latest Drugdevelopment Feature

Less is more: why rare disease funding is on the up
02 February, 2012
Despite reductions in R&D spending, clinical trials for rare diseases are going full steam ahead. Elly Earls speaks to Alastair Kent of Genetic Alliance UK, Tim Cote of the National...
> read more
Pharma Technology Focus - Issue 9 25 January, 2012 In this issue we investigate how rapidly evolving drug delivery methods are helping to make medicines more...

Going with the flow: continuous manufacturing 23 January, 2012 As manufacturing models embrace process analytical technology, big pharma has to reassess the way it produces drugs. Elisabeth Fischer profiles the opportunities and stumbling blocks of...

By Category

International drug discovery – breaking new ground at Dubai 2012 18 January, 2012 The fourth International Conference on Drug Discovery and Therapy provides a unique platform for collaboration. Drugdevelopment-technology.com previews the big issues and breakthroughs that will...

Snapshot: The market for neuropathic pain therapeutics 06 January, 2012 As conditions such as diabetes become more common, the market for new pain drugs is becoming increasingly competitive. Using detailed GlobalData research this snapshot examines the market...

Future oncology: The path to personalised medicine 19 December, 2011 Could the genetic screening of tumour tissues push oncology into the era of personalised patient cancer treatment? Elisabeth Fischer talks to the researchers of the Stratified Cancer Programme...

Pharma Technology Focus - Issue 8 14 December, 2011 In this issue we look at securing supply chains and optimising...

Enhancing bioavailability 08 December, 2011 Poor solubility can be critical for otherwise life-saving drugs, but new information could herald a welcome solution. Elly Earls speaks to John Comer of Sirius Analytical and Dr Woei Ping Cheng...

Take a load off: the age of cloud computing 21 November, 2011 Excessive, unmanageable data may be to blame for low productivity rates in the drug industry. Sarah Blackman looks at how cloud computing can streamline this data to make information...

Taking aim with nanotechnology 16 November, 2011 One of the key challenges of drug delivery is ensuring the right dose reaches the target without damaging healthy cells. Richard Moore of the Institute of Nanotechnology and inventor,...

Pharma Technology Focus – Issue 7 16 November, 2011 Finding new cures: This month we look at trends and progress in drug discovery and...

A new era of drug safety: European pharmacovigilance 09 November, 2011 The introduction of a new law on pharmacovigilance is set to revolutionise European drug safety in years to come. In the run-up to Arena International's Pharmacovigilance, Drug Safety and...

That's teamwork: Pharma puts its faith in partnerships 24 October, 2011 As big pharma looks for new drugs to replace expired patents, research partnerships are becoming increasingly popular. Chris Lo looks at how pharmaceutical companies are throwing their...

View all features a-z